Cite
HARVARD Citation
Chen, X. et al. (2016). A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate. Clinical rheumatology. 35 (9), pp. 2175-2183. [Online].